Bahrain

8 Vaccines Approved for Use in Bahrain

RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: abcnews.go.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
6 trials in 2 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Serum Institute of India

Covishield (Oxford/ AstraZeneca formulation)

Approved in 49 countries
3 trials in 1 country
Approval Source: arabnews.com
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
13 trials in 2 countries
Approval Source: bna.bh
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: nature.com
Inactivated

Valneva

VLA2001

Approved in 2 countries
6 trials in 3 countries
Approval Source: english.alarabiya.net

2 in Clinical Trials in Bahrain

Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries